We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News   Oct 16, 2019

 
Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Movers and Shakers in Biobusiness Report

Product News

The seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.

READ MORE

Iksuda Therapeutics Enters Agreement With University of Goettingen To Develop Novel Antibody Drug Conjugates

Product News

Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of Goettingen, following a successful collaboration exemplifying the series in ADC formats.

READ MORE

Sartorius Releases the 4th Edition of its Live-Cell Analysis Handbook

Product News

The handbook was first launched in 2017 as a comprehensive reference guide for live-cell analysis technologies, with a focus on the complete suite of Incucyte® live-cell assays and reagents.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE